ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Gut microbiome in tumorigenesis and therapy of colorectal cancer

Wang, Ling; Yu, Ke-Chun; Hou, Yun-qing; Guo, Min; Yao, Fan; Chen, Zhen-Xia*华中农业大学
Journal of Cellular Physiology2023-1DOI: 10.1002/jcp.30917
4被引6阅读
引用收藏
分享

摘要

Colorectal cancer (CRC) is the malignant tumor with the highest incidence in the digestive system, and the gut microbiome plays a crucial role in CRC tumorigenesis and therapy. The gastrointestinal tract is the organ harboring most of the microbiota in humans. Changes in the gut microbiome in CRC patients suggest possible host-microbe interactions, thereby hinting the potential tumorigenesis, which provides new perspective for preventing, diagnosing, or treating CRC. In this review, we discuss the effects of gut microbiome dysbiosis on CRC, and reveal the mechanisms by which gut microbiome dysbiosis leads to CRC. Gut microbiome modulation with the aim to reverse the established gut microbial dysbiosis is a novel strategy for the prevention and treatment of CRC. In addition, this review summarizes that probiotic antagonize CRC tumorigenesis by protecting intestinal barrier function, inhibiting cancer cell proliferation, resisting oxidative stress, and enhancing host immunity. Finally, we highlight clinical applications of the gut microbiome, such as gut microbiome analysis-based biomarker screening and prediction, and microbe modulation-based CRC prevention, treatment enhancement, and treatment side effect reduction. This review provides the reference for the clinical application of gut microbiome in the prevention and treatment of CRC.

学科与关键词

关键词
biomarkersCRCgut microbiomeprobioticstumorigenesis
相关
加载中…
  • Role of microbes in colorectal cancer therapy: Cross-talk between the microbiome and tumor microenvironment
    Xia, Cong; Cai, Yantao; Ren, Shuangyi*; Xia, Chenglai*Frontiers in Pharmacology, 2022, 13: 1051330.被引 4
  • Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism
    Ou, Suwen; Wang, Hufei; Tao, Yangbao; Luo, Kangjia; Ye, Jinhua; Ran, Songlin; Guan, Zilong; Wang, Yuliuming; Hu, Hanqing; Huang, Rui*Frontiers in Cellular and Infection Microbiology, 2022, 12: 1020583.被引 10
  • Microbial Metabolites in Colorectal Cancer: Basic and Clinical Implications
    Peng, Yao; Nie, Yugiang; Yu, Jun*; Wong, Chi Chun*Metabolites, 2021, 11(3): 159.被引 21
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Cellular Physiology
发表日期
2023-01
卷期
第 238 卷, 第 1 期
页码
94-108
DOI
10.1002/jcp.30917
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [31871305]; Science and Technology major program of Hubei Province [2021ABA011]; Foundation of Hubei Hongshan Laboratory [2021hszd012, 2022hszd024, 2022hszd028]; Fundamental Research Funds for the Central Universities [2662020PY001]; HZAU-AGIS Cooperation Fund [SZYJY2021010]; Huazhong Agricultural University Scientific & Technological Self-innovation Foundation [2016RC011]

作者

  • W

    Wang, Ling (第一作者)

    huazhong agr univ · chinese acad agr sci

  • Y

    Yu, Ke-Chun

    huazhong agr univ

查看全部 6 位作者收起作者
  • H

    Hou, Yun-qing

    huazhong agr univ

  • G

    Guo, Min

    huazhong agr univ

  • Y

    Yao, Fan

    huazhong agr univ

  • C

    Chen, Zhen-Xia (通讯)

    huazhong agr univ · chinese acad agr sci

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417